Ajanta Pharma Shareholding Pattern
- Market cap
- ₹44,673 crore
- P/E
- 39.4
- P/B
- 9.87
- ROE
- 25.4%
- Dividend yield
- 0.89%
As of 30-JUN-2026, promoters held 63.48% of Ajanta Pharma (-2.77 pp from 31-MAR-2026), foreign institutional investors 7.68%, domestic institutions 21.80% and the public 7.03%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Ajanta Pharma shareholding pattern — frequently asked questions
What is the promoter holding in Ajanta Pharma?
Promoters held 63.48% of Ajanta Pharma as of 30-JUN-2026, down 2.77 pp from 66.25% in 31-MAR-2026.
How much do FIIs hold in Ajanta Pharma?
Foreign institutional investors held 7.68% of Ajanta Pharma as of 30-JUN-2026, a change of -0.58 pp from the previous quarter.
How much do domestic institutions hold in Ajanta Pharma?
Domestic institutional investors, including mutual funds and insurers, held 21.80% of Ajanta Pharma as of 30-JUN-2026 (+3.43 pp from the previous quarter).
Who owns Ajanta Pharma?
As of 30-JUN-2026, Ajanta Pharma's shareholders were promoters (63.48%), foreign institutional investors 7.68%, domestic institutions 21.80% and the public 7.03%, as filed with the stock exchanges.
Same Data For Peers
Trade Ajanta Pharma With ATS
Track AJANTPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.